These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 19515761)

  • 1. Structural and functional elements of the promoter encoded by the 5' untranslated region of the Venezuelan equine encephalitis virus genome.
    Kulasegaran-Shylini R; Atasheva S; Gorenstein DG; Frolov I
    J Virol; 2009 Sep; 83(17):8327-39. PubMed ID: 19515761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 5'UTR-specific mutation in VEEV TC-83 genome has a strong effect on RNA replication and subgenomic RNA synthesis, but not on translation of the encoded proteins.
    Kulasegaran-Shylini R; Thiviyanathan V; Gorenstein DG; Frolov I
    Virology; 2009 Apr; 387(1):211-21. PubMed ID: 19278709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypervariable domain of nonstructural protein nsP3 of Venezuelan equine encephalitis virus determines cell-specific mode of virus replication.
    Foy NJ; Akhrymuk M; Shustov AV; Frolova EI; Frolov I
    J Virol; 2013 Jul; 87(13):7569-84. PubMed ID: 23637407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in Hypervariable Domain of Venezuelan Equine Encephalitis Virus nsP3 Protein Differentially Affect Viral Replication.
    Meshram CD; Phillips AT; Lukash T; Shiliaev N; Frolova EI; Frolov I
    J Virol; 2020 Jan; 94(3):. PubMed ID: 31694937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ablation of Programmed -1 Ribosomal Frameshifting in Venezuelan Equine Encephalitis Virus Results in Attenuated Neuropathogenicity.
    Kendra JA; de la Fuente C; Brahms A; Woodson C; Bell TM; Chen B; Khan YA; Jacobs JL; Kehn-Hall K; Dinman JD
    J Virol; 2017 Feb; 91(3):. PubMed ID: 27852852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Venezuelan Equine Encephalitis Virus nsP3 Phosphorylation Can Be Mediated by IKKβ Kinase Activity and Abrogation of Phosphorylation Inhibits Negative-Strand Synthesis.
    Bakovic A; Bhalla N; Kortchak S; Sun C; Zhou W; Ahmed A; Risner K; Klimstra WB; Narayanan A
    Viruses; 2020 Sep; 12(9):. PubMed ID: 32933112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adaptation of Venezuelan equine encephalitis virus lacking 51-nt conserved sequence element to replication in mammalian and mosquito cells.
    Michel G; Petrakova O; Atasheva S; Frolov I
    Virology; 2007 Jun; 362(2):475-87. PubMed ID: 17292936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inactivation of Venezuelan Equine Encephalitis Virus Genome Using Two Methods.
    Behnia M; Baer A; Skidmore AM; Lehman CW; Bracci N; Kehn-Hall K; Bradfute SB
    Viruses; 2022 Jan; 14(2):. PubMed ID: 35215864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant sindbis/Venezuelan equine encephalitis virus is highly attenuated and immunogenic.
    Paessler S; Fayzulin RZ; Anishchenko M; Greene IP; Weaver SC; Frolov I
    J Virol; 2003 Sep; 77(17):9278-86. PubMed ID: 12915543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of a novel compound with anti-venezuelan equine encephalitis virus activity that targets the nonstructural protein 2.
    Chung DH; Jonsson CB; Tower NA; Chu YK; Sahin E; Golden JE; Noah JW; Schroeder CE; Sotsky JB; Sosa MI; Cramer DE; McKellip SN; Rasmussen L; White EL; Schmaljohn CS; Julander JG; Smith JM; Filone CM; Connor JH; Sakurai Y; Davey RA
    PLoS Pathog; 2014 Jun; 10(6):e1004213. PubMed ID: 24967809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current Understanding of the Molecular Basis of Venezuelan Equine Encephalitis Virus Pathogenesis and Vaccine Development.
    Sharma A; Knollmann-Ritschel B
    Viruses; 2019 Feb; 11(2):. PubMed ID: 30781656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The SD1 Subdomain of Venezuelan Equine Encephalitis Virus Capsid Protein Plays a Critical Role in Nucleocapsid and Particle Assembly.
    Reynaud JM; Lulla V; Kim DY; Frolova EI; Frolov I
    J Virol; 2016 Feb; 90(4):2008-20. PubMed ID: 26656680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure and Sequence Requirements for RNA Capping at the Venezuelan Equine Encephalitis Virus RNA 5' End.
    Ortega Granda O; Valle C; Shannon A; Decroly E; Canard B; Coutard B; Rabah N
    J Virol; 2021 Jul; 95(15):e0077721. PubMed ID: 34011549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interplay of acute and persistent infections caused by Venezuelan equine encephalitis virus encoding mutated capsid protein.
    Atasheva S; Krendelchtchikova V; Liopo A; Frolova E; Frolov I
    J Virol; 2010 Oct; 84(19):10004-15. PubMed ID: 20668087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The amino-terminal domain of alphavirus capsid protein is dispensable for viral particle assembly but regulates RNA encapsidation through cooperative functions of its subdomains.
    Lulla V; Kim DY; Frolova EI; Frolov I
    J Virol; 2013 Nov; 87(22):12003-19. PubMed ID: 24006447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benzamidine ML336 inhibits plus and minus strand RNA synthesis of Venezuelan equine encephalitis virus without affecting host RNA production.
    Skidmore AM; Adcock RS; Jonsson CB; Golden JE; Chung DH
    Antiviral Res; 2020 Feb; 174():104674. PubMed ID: 31816348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Artificial microRNAs can effectively inhibit replication of Venezuelan equine encephalitis virus.
    Bhomia M; Sharma A; Gayen M; Gupta P; Maheshwari RK
    Antiviral Res; 2013 Nov; 100(2):429-34. PubMed ID: 23988697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel DNA-launched Venezuelan equine encephalitis virus vaccine with rearranged genome.
    Tretyakova I; Tibbens A; Jokinen JD; Johnson DM; Lukashevich IS; Pushko P
    Vaccine; 2019 May; 37(25):3317-3325. PubMed ID: 31072736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IFIT1 Differentially Interferes with Translation and Replication of Alphavirus Genomes and Promotes Induction of Type I Interferon.
    Reynaud JM; Kim DY; Atasheva S; Rasalouskaya A; White JP; Diamond MS; Weaver SC; Frolova EI; Frolov I
    PLoS Pathog; 2015 Apr; 11(4):e1004863. PubMed ID: 25927359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selection of functional 5' cis-acting elements promoting efficient sindbis virus genome replication.
    Gorchakov R; Hardy R; Rice CM; Frolov I
    J Virol; 2004 Jan; 78(1):61-75. PubMed ID: 14671088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.